Indian scientists successfully use gene therapy to treat severe haemophilia A, a rare hereditary condition with promising ...

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...

In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...

Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral vector-based gene therapy ? ET3 ? for hemophilia A at the Annual Meeting of the American ...

Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...

India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...

PRO-LIFE Christians often quote biblical scripture in their defense of unborn human life. They are committed to the belief ...

Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading ...

During his opening remarks, Minister of Health, Dr Frank Anthony, highlighted the ministry’s ambition to transition from malaria control to elimination. He ...